INDOCO REMEDIES : MHRA INSPECTS SOLID DOSAGES FACILITY

• UK MHRA inspected the company's manufacturing facility at Plant I (solid oral dosage form) in Goa from September 7 to September 9, 2026. • The inspection concluded with no critical or major observations, reinforcing quality standards and regulatory compliance. • The facility manufactures solid and liquid dosages and is approved by USFDA, TGA-Australia, EU Malta, and holds WHO-GMP approval.

Indoco Remedies Limited

Open attachment

← Back to feed